ISID Home
about ISID | membership | programs | publications | resources | 14th ICID | site map
 
ProMed Home
  
  Search Criteria |    Display Report |    Search Help 
 
  Navigation
Home
Subscribe/Unsubscribe
Search Archives
Announcements
Recalls/Alerts
Calendar of Events
Maps of Outbreaks
Submit Info
FAQs
Who's Who
Awards
Citing ProMED-mail
Links
Donations
About ProMED-mail
 
Archive Number 20090218.0669
Published Date 18-FEB-2009
Subject PRO/AH/EDR> Lassa fever - Nigeria

LASSA FEVER - NIGERIA
*********************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Mon 16 Feb 2009
Source: AllAfrica, This Day report [edited]
<http://allafrica.com/stories/200902160188.html>


Nigeria: Lassa fever -- specialist expresses concern over spread
----------------------------------------------------------------
The chief medical director of Irrua Specialist Hospital, Prof George 
Akpede, has expressed concern over the wide spread of Lassa fever in 
recent times, disclosing that out of 229 suspected cases reported 
between January and December 2008, 30 people died.

Prof Akpede, who spoke at National Lassa Fever Stakeholders Forum at 
Ekpoma [at the] weekend [14-15 Feb 2009] noted that there had been a 
marked rise in the number of suspected and confirmed cases between 
December 2008 and January 2009 representing about 60 percent and 80 
percent increases respectively. He, however, disclosed that some 
drastic measures were under way as the Irrua Specialist Teaching 
Hospital had entered into partnerships with Behard-Notch Institute of 
Tropical Medicine, Hamburg, Germany, and Harvard University, USA for 
collaboration in Lassa fever research and control efforts. Part of 
the collaboration, according to him, had resulted in the donation of 
diagnostic facilities for the confirmation of the disease in the 
hospital without samples having to be sent out of the country any longer.

In his contribution, [the] member representing Esan Central/Esan 
West/Igueben Federal Constituency in the House of Representatives, 
Mr. Patrick Ikhariale, also expressed concern over the spread of the 
Lassa fever epidemic nation-wide and called for urgent control 
measures at the national level. Ikhariale assured that he would draw 
the attention of the National Assembly to the menace posed by the 
disease to millions of Nigerians.

[Byline: Adibe Emenyonu]

--
Communicated by:
ProMED-mail Rapporteur A-Lan Banks

[Lassa fever is a zoonotic disease, whereby humans become infected 
from contact with infected animals. The animal reservoirs of Lassa 
virus are rodents of the genus _Mastomys_, the "multimammate rat." 
Lassa virus-infected animals do not become ill, but they can shed the 
virus in their urine and faeces. (A photograph of a multimammate rat 
can be accessed at
<http://i127.photobucket.com/albums/p145/hawthornrats/other%20pets/multis/DSCF4892.jpg>).

In humans Lassa viral haemorrhagic fever is an acute illness of 1-4 
weeks duration that occurs in West Africa. The virus is a 
single-stranded RNA virus belonging to the virus family 
_Arenaviridae_. Lassa fever is known to be endemic in Guinea 
(Conakry), Liberia, Sierra Leone, and parts of Nigeria, but probably 
exists in other West African countries as well.

About 80 percent of human infections are asymptomatic; the remaining 
cases have severe multi-system disease, where the virus affects 
several organs in the body, such as the liver, spleen, and kidneys. 
The incubation period of Lassa fever ranges from 6-21 days. It has 
been estimated that about 300 000 to 500 000 cases of Lassa fever and 
5000 deaths occur yearly across West Africa. The overall 
case-fatality rate is 1 percent, and up to 15 percent among 
hospitalized patients.

The disease is especially severe late in pregnancy, with maternal 
death and/or fetal loss occurring in greater than 80 percent of cases 
during the 3rd trimester.

Humans usually become infected with Lassa virus from exposure to 
excreta of infected _Mastomys_. Lassa virus may also be spread 
between humans through direct contact with the blood, urine, faeces, 
or other bodily secretions of a person with Lassa fever. There is no 
epidemiological evidence supporting airborne spread between humans. 
Person-to-person transmission occurs in both community and health 
care settings, where the virus may be spread by contaminated medical 
equipment, such as re-used needles.

The current increase in cases of Lassa fever in some parts of Nigeria 
may by a consequence of increased abundance of the vector or some 
other factor resulting in increased contact between humans and 
rodents promoting the spread of the disease in the human population. - Mod.CP

The HealthMap/ProMED-mail interactive map of Nigeria is available at
<http://healthmap.org/promed/en?v=9.6,6.1,6>. - CopyEd.MJ]

[see also:
Lassa fever - UK ex Nigeria (03): fatal 20090130.0414
Lassa fever - UK ex Nigeria (02) 20090124.0308
Lassa fever - UK ex Nigeria 20090123.0296
2008
-----
Lassa fever - Nigeria (02) 20080611.1847
Lassa fever - Nigeria: (Ebonyi) 20080323.1100
2007
----
Lassa fever - Nigeria 20071205.3925
Lassa Fever - South Africa ex Nigeria 20070222.0657
2005
----
Lassa fever - Nigeria (Edo) 20050303.0654
2004
----
Lassa fever - Nigeria (Edo) 20040214.0487
Lassa fever - Nigeria: RFI 20040213.0482
2001
----
Lassa fever, suspected - Nigeria (Edo) (02) 20010319.0552
Lassa fever, suspected - Nigeria (Edo): RFI 20010315.0524
2000
----
Lassa fever - Germany ex Nigeria (03) 20000424.0609
Lassa fever - Germany ex Nigeria (02) 20000405.0497
Lassa fever - Germany ex Nigeria 20000404.0495]
...................................cp/mj/dk

*##########################################################*
************************************************************
ProMED-mail makes every effort to  verify  the reports  that
are  posted,  but  the  accuracy  and  completeness  of  the
information,   and  of  any  statements  or  opinions  based
thereon, are not guaranteed. The reader assumes all risks in
using information posted or archived by  ProMED-mail.   ISID
and  its  associated  service  providers  shall not be  held
responsible for errors or omissions or  held liable for  any
damages incurred as a result of use or reliance upon  posted
or archived material.
************************************************************
Become     a    ProMED-mail    Premium     Subscriber     at
<http://www.isid.org/ProMEDMail_Premium.shtml>
************************************************************
Visit ProMED-mail's web site at <http://www.promedmail.org>.
Send  all  items  for   posting  to:   promed@promedmail.org

(NOT to  an  individual moderator).  If you do not give your
full name and  affiliation, it  may  not  be  posted.   Send
commands  to  subscribe/unsubscribe,   get  archives,  help,
etc. to: majordomo@promedmail.org.    For assistance  from a
human  being  send  mail  to:   owner-promed@promedmail.org.

############################################################
############################################################

about ISID | membership | programs | publications | resources
14th ICID | site map | ISID home

©2001,2009 International Society for Infectious Diseases
All Rights Reserved.
Read our privacy guidelines.
Use of this web site and related services is governed by the Terms of Service.